Papers associated with kcnq2

???displayGene.coCitedPapers???

???pagination.result.count???

???pagination.result.page??? 1 2 ???pagination.result.next???

Sort Newest To Oldest

Sort Oldest To Newest

referenced by:

	Distinctive mechanisms of epilepsy-causing mutants discovered by measuring S4 movement in KCNQ2 channels., Edmond MA, Hinojo-Perez A, Wu X, Perez Rodriguez ME, Barro-Soria R., Elife. June 1, 2022; 11
	A convergent molecular network underlying autism and congenital heart disease., Rosenthal SB, Willsey HR, Xu Y, Xu Y, Mei Y, Dea J, Wang S, Curtis C, Sempou E, Khokha MK, Chi NC, Willsey AJ, Fisch KM, Ideker T., Cell Syst. November 17, 2021; 12 (11): 1094-1107.e6.
	The Amyloid Precursor Protein C99 Fragment Modulates Voltage-Gated Potassium Channels., Manville RW, Abbott GW., Cell Physiol Biochem. July 28, 2021; 55 (S3): 157-170.
	Familial neonatal seizures caused by the Kv7.3 selectivity filter mutation T313I., Maghera J, Li J, Lamothe SM, Braun M, Appendino JP, Au PYB, Kurata HT., Epilepsia Open. December 1, 2020; 5 (4): 562-573.
	Heteromeric Assembly of Truncated Neuronal Kv7 Channels: Implications for Neurologic Disease and Pharmacotherapy., Li J, Maghera J, Lamothe SM, Marco EJ, Kurata HT., Mol Pharmacol. September 1, 2020; 98 (3): 192-202.
	Isoform-Selective KCNA1 Potassium Channel Openers Built from Glycine., Manville RW, Abbott GW., J Pharmacol Exp Ther. June 1, 2020; 373 (3): 391-401.
	M-Channel Activation Contributes to the Anticonvulsant Action of the Ketone Body β-Hydroxybutyrate., Manville RW, Papanikolaou M, Abbott GW., J Pharmacol Exp Ther. February 1, 2020; 372 (2): 148-156.
	Epilepsy-associated mutations in the voltage sensor of KCNQ3 affect voltage dependence of channel opening., Barro-Soria R., J Gen Physiol. February 4, 2019; 151 (2): 247-257.
	In silico re-engineering of a neurotransmitter to activate KCNQ potassium channels in an isoform-specific manner., Manville RW, Abbott GW., Commun Biol. January 1, 2019; 2 401.
	Deconstruction of an African folk medicine uncovers a novel molecular strategy for therapeutic potassium channel activation., De Silva AM, Manville RW, Abbott GW., Sci Adv. November 14, 2018; 4 (11): eaav0824.
	Gabapentin Is a Potent Activator of KCNQ3 and KCNQ5 Potassium Channels., Manville RW, Abbott GW., Mol Pharmacol. October 1, 2018; 94 (4): 1155-1163.
	One drug-sensitive subunit is sufficient for a near-maximal retigabine effect in KCNQ channels., Yau MC, Kim RY, Wang CK, Li J, Ammar T, Yang RY, Pless SA, Kurata HT., J Gen Physiol. October 1, 2018; 150 (10): 1421-1431.
	Ancient and modern anticonvulsants act synergistically in a KCNQ potassium channel binding pocket., Manville RW, Abbott GW., Nat Commun. September 21, 2018; 9 (1): 3845.
	Direct neurotransmitter activation of voltage-gated potassium channels., Manville RW, Papanikolaou M, Abbott GW., Nat Commun. May 10, 2018; 9 (1): 1847.
	PIP2 mediates functional coupling and pharmacology of neuronal KCNQ channels., Kim RY, Pless SA, Kurata HT., Proc Natl Acad Sci U S A. November 7, 2017; 114 (45): E9702-E9711.
	KCNQ-SMIT complex formation facilitates ion channel-solute transporter cross talk., Neverisky DL, Abbott GW., FASEB J. July 1, 2017; 31 (7): 2828-2838.
	A novel muscarinic receptor-independent mechanism of KCNQ2/3 potassium channel blockade by Oxotremorine-M., Zwart R, Reed H, Clarke S, Sher E., Eur J Pharmacol. November 15, 2016; 791 221-228.
	Novel KCNQ3 Mutation in a Large Family with Benign Familial Neonatal Epilepsy: A Rare Cause of Neonatal Seizures., Maljevic S, Vejzovic S, Bernhard MK, Bertsche A, Weise S, Döcker M, Lerche H, Lemke JR, Merkenschlager A, Syrbe S., Mol Syndromol. September 1, 2016; 7 (4): 189-196.
	Regulation of the neuronal KCNQ2 channel by Src--a dual rearrangement of the cytosolic termini underlies bidirectional regulation of gating., Siloni S, Singer-Lahat D, Esa M, Tsemakhovich V, Chikvashvili D, Lotan I., J Cell Sci. September 15, 2015; 128 (18): 3489-501.
	Atomic basis for therapeutic activation of neuronal potassium channels., Kim RY, Yau MC, Galpin JD, Seebohm G, Ahern CA, Pless SA, Kurata HT., Nat Commun. September 3, 2015; 6 8116.
	Capturing distinct KCNQ2 channel resting states by metal ion bridges in the voltage-sensor domain., Gourgy-Hacohen O, Kornilov P, Pittel I, Peretz A, Attali B, Paas Y., J Gen Physiol. December 1, 2014; 144 (6): 513-27.
	Dominant-negative effects of KCNQ2 mutations are associated with epileptic encephalopathy., Orhan G, Bock M, Schepers D, Ilina EI, Reichel SN, Löffler H, Jezutkovic N, Weckhuysen S, Mandelstam S, Suls A, Danker T, Guenther E, Scheffer IE, De Jonghe P, Lerche H, Maljevic S., Ann Neurol. March 1, 2014; 75 (3): 382-94.
	Dynamic PIP2 interactions with voltage sensor elements contribute to KCNQ2 channel gating., Zhang Q, Zhou P, Chen Z, Li M, Jiang H, Gao Z, Yang H., Proc Natl Acad Sci U S A. December 10, 2013; 110 (50): 20093-8.
	The linker pivot in Ci-VSP: the key to unlock catalysis., Hobiger K, Utesch T, Mroginski MA, Seebohm G, Friedrich T., PLoS One. July 1, 2013; 8 (7): e70272.
	Dysfunction of the Heteromeric KV7.3/KV7.5 Potassium Channel is Associated with Autism Spectrum Disorders., Gilling M, Rasmussen HB, Calloe K, Sequeira AF, Baretto M, Oliveira G, Almeida J, Lauritsen MB, Ullmann R, Boonen SE, Brondum-Nielsen K, Kalscheuer VM, Tümer Z, Vicente AM, Schmitt N, Tommerup N., Front Genet. April 16, 2013; 4 54.
	The new KCNQ2 activator 4-Chlor-N-(6-chlor-pyridin-3-yl)-benzamid displays anticonvulsant potential., Boehlen A, Schwake M, Dost R, Kunert A, Fidzinski P, Heinemann U, Gebhardt C., Br J Pharmacol. March 1, 2013; 168 (5): 1182-200.
	Impaired ion channel function related to a common KCNQ1 mutation - implications for risk stratification in long QT syndrome 1., Aidery P, Kisselbach J, Schweizer PA, Becker R, Katus HA, Thomas D., Gene. December 10, 2012; 511 (1): 26-33.
	De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy., Barcia G, Fleming MR, Deligniere A, Gazula VR, Brown MR, Langouet M, Chen H, Kronengold J, Abhyankar A, Cilio R, Nitschke P, Kaminska A, Boddaert N, Casanova JL, Desguerre I, Munnich A, Dulac O, Kaczmarek LK, Colleaux L, Nabbout R., Nat Genet. November 1, 2012; 44 (11): 1255-9.
	Coupling of Ci-VSP modules requires a combination of structure and electrostatics within the linker., Hobiger K, Utesch T, Mroginski MA, Friedrich T., Biophys J. March 21, 2012; 102 (6): 1313-22.
	Surface expression and subunit specific control of steady protein levels by the Kv7.2 helix A-B linker., Aivar P, Fernández-Orth J, Gomis-Perez C, Alberdi A, Alaimo A, Rodríguez MS, Giraldez T, Miranda P, Areso P, Villarroel A., PLoS One. January 1, 2012; 7 (10): e47263.
	Membrane depolarization increases membrane PtdIns(4,5)P2 levels through mechanisms involving PKC βII and PI4 kinase., Chen X, Zhang X, Jia C, Xu J, Gao H, Zhang G, Du X, Zhang H., J Biol Chem. November 18, 2011; 286 (46): 39760-7.
	KCNQ1 subdomains involved in KCNE modulation revealed by an invertebrate KCNQ1 orthologue., Nakajo K, Nishino A, Okamura Y, Kubo Y., J Gen Physiol. November 1, 2011; 138 (5): 521-35.
	Regulation of neuronal M-channel gating in an isoform-specific manner: functional interplay between calmodulin and syntaxin 1A., Etzioni A, Siloni S, Chikvashvilli D, Strulovich R, Sachyani D, Regev N, Greitzer-Antes D, Hirsch JA, Lotan I., J Neurosci. October 5, 2011; 31 (40): 14158-71.
	Extracellular potassium inhibits Kv7.1 potassium channels by stabilizing an inactivated state., Larsen AP, Steffensen AB, Grunnet M, Olesen SP., Biophys J. August 17, 2011; 101 (4): 818-27.
	A pore residue of the KCNQ3 potassium M-channel subunit controls surface expression., Gómez-Posada JC, Etxeberría A, Roura-Ferrer M, Areso P, Masin M, Murrell-Lagnado RD, Villarroel A., J Neurosci. July 7, 2010; 30 (27): 9316-23.
	The KCNQ5 potassium channel mediates a component of the afterhyperpolarization current in mouse hippocampus., Tzingounis AV, Heidenreich M, Kharkovets T, Spitzmaul G, Jensen HS, Nicoll RA, Jentsch TJ., Proc Natl Acad Sci U S A. June 1, 2010; 107 (22): 10232-7.
	Pharmacological characterization of a novel positive modulator at alpha 4 beta 3 delta-containing extrasynaptic GABA(A) receptors., Hoestgaard-Jensen K, Dalby NO, Wolinsky TD, Murphey C, Jones KA, Rottländer M, Frederiksen K, Watson WP, Jensen K, Ebert B., Neuropharmacology. January 1, 2010; 58 (4-5): 702-11.
	The acrylamide (S)-2 as a positive and negative modulator of Kv7 channels expressed in Xenopus laevis oocytes., Blom SM, Schmitt N, Jensen HS., PLoS One. December 11, 2009; 4 (12): e8251.
	Selective interaction of syntaxin 1A with KCNQ2: possible implications for specific modulation of presynaptic activity., Regev N, Degani-Katzav N, Korngreen A, Etzioni A, Siloni S, Alaimo A, Chikvashvili D, Villarroel A, Attali B, Lotan I., PLoS One. August 13, 2009; 4 (8): e6586.
	Calmodulin activation limits the rate of KCNQ2 K+ channel exit from the endoplasmic reticulum., Alaimo A, Gómez-Posada JC, Aivar P, Etxeberría A, Rodriguez-Alfaro JA, Areso P, Villarroel A., J Biol Chem. July 31, 2009; 284 (31): 20668-75.
	Coupling between the voltage-sensing and phosphatase domains of Ci-VSP., Villalba-Galea CA, Miceli F, Taglialatela M, Bezanilla F., J Gen Physiol. July 1, 2009; 134 (1): 5-14.
	KCNQ2 and KCNQ3 mutations contribute to different idiopathic epilepsy syndromes., Neubauer BA, Waldegger S, Heinzinger J, Hahn A, Kurlemann G, Fiedler B, Eberhard F, Muhle H, Stephani U, Garkisch S, Eeg-Olofsson O, Müller U, Sander T., Neurology. July 15, 2008; 71 (3): 177-83.
	Regulation of the voltage-gated K(+) channels KCNQ2/3 and KCNQ3/5 by serum- and glucocorticoid-regulated kinase-1., Schuetz F, Kumar S, Poronnik P, Adams DJ., Am J Physiol Cell Physiol. July 1, 2008; 295 (1): C73-80.
	A schizophrenia-linked mutation in PIP5K2A fails to activate neuronal M channels., Fedorenko O, Strutz-Seebohm N, Henrion U, Ureche ON, Lang F, Seebohm G, Lang UE., Psychopharmacology (Berl). July 1, 2008; 199 (1): 47-54.
	Enzyme domain affects the movement of the voltage sensor in ascidian and zebrafish voltage-sensing phosphatases., Hossain MI, Iwasaki H, Okochi Y, Chahine M, Higashijima S, Nagayama K, Okamura Y., J Biol Chem. June 27, 2008; 283 (26): 18248-59.
	Second coiled-coil domain of KCNQ channel controls current expression and subfamily specific heteromultimerization by salt bridge networks., Nakajo K, Kubo Y., J Physiol. June 15, 2008; 586 (12): 2827-40.
	Neutralization of a negative charge in the S1-S2 region of the KV7.2 (KCNQ2) channel affects voltage-dependent activation in neonatal epilepsy., Wuttke TV, Penzien J, Fauler M, Seebohm G, Lehmann-Horn F, Lerche H, Jurkat-Rott K., J Physiol. January 15, 2008; 586 (2): 545-55.
	Peripheral nerve hyperexcitability due to dominant-negative KCNQ2 mutations., Wuttke TV, Jurkat-Rott K, Paulus W, Garncarek M, Lehmann-Horn F, Lerche H., Neurology. November 27, 2007; 69 (22): 2045-53.
	Chromanol 293B binding in KCNQ1 (Kv7.1) channels involves electrostatic interactions with a potassium ion in the selectivity filter., Lerche C, Bruhova I, Lerche H, Steinmeyer K, Wei AD, Strutz-Seebohm N, Lang F, Busch AE, Zhorov BS, Seebohm G., Mol Pharmacol. June 1, 2007; 71 (6): 1503-11.
	Modulation of ERG channels by XE991., Elmedyb P, Calloe K, Schmitt N, Hansen RS, Grunnet M, Olesen SP., Basic Clin Pharmacol Toxicol. May 1, 2007; 100 (5): 316-22.

???pagination.result.page??? 1 2 ???pagination.result.next???